In The Presence Of CK8 And CK18, Breast Cancer Drug Fulvestrant Appears More Effectiv
Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy...